Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

rhIGF-1 improves lipid profiles in adults with IDDM

Oct. 23, 1997

Ligand and Lilly enter drug discovery and development alliance for metabolic drugs

Oct. 23, 1997

Endocrinologic and Metabolic Drugs Advisory Committee meets in late November

Oct. 22, 1997

Mechanism of cytoprotective effects of bimoclomol

Oct. 22, 1997

Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor

Oct. 22, 1997

Romozin now available in U.K.

Oct. 22, 1997

New estrogen receptor ligand reported by Glaxo Wellcome

Oct. 22, 1997

ArQule and Acacia to develop novel drug candidates

Oct. 22, 1997

Megestrol + ibuprofen for cancer cachexia

Oct. 21, 1997

First launch for Yamanouchi bisphosphonate

Oct. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...